Currently, the molecular subtypes of BC (luminal A and B, triple negative and human epidermal growth factor receptor 2-overexpressed (HER2-overexpressed) are also included as elements that strongly influence survival, since they completely modify the treatment schemes [4]. The gene discussed is ERBB2; the disease is breast cancer.